Indication
Locally Advanced Solid Tumours
1 clinical trial
1 product
Product
AZD1775Clinical trial
A Phase Ib Study to Determine the Maximum Tolerated Dose (MTD) of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.Status: Completed, Estimated PCD: 2018-04-26